Dana Investment Advisors Inc. raised its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 57.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 57,559 shares of the biopharmaceutical company’s stock after acquiring an additional 20,932 shares during the quarter. Dana Investment Advisors […]
TG Therapeutics shares were up more than 30% in recent trading on Wednesday after the company reported a Q4 net loss of $0.09 per diluted share compared with $0.39 a year earlier.
Analysts.
TG Therapeutics (NASDAQ:TGTX – Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.03, Briefing.com reports. The company had revenue of $43.97 million during the quarter, compared to the consensus estimate of $40.06 million. TG Therapeutics had […]
TG Therapeutics (NASDAQ:TGTX) Issues Earnings Results themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ: TGTX) has recently received a number of price target changes and ratings updates: 2/29/2024 – TG Therapeutics had its price target raised by analysts at The Goldman Sachs Group, Inc. from $12.00 to $13.00. They now have a “neutral” rating on the stock. 2/28/2024 – TG Therapeutics had its “buy” rating reaffirmed […]